A Phase I Open-Label, Multi-Dose Escalation Study of the Dual Syk/Jak Inhibitor PRT062070 (Cerdulatinib) in Patients with Relapsed/Refractory B Cell Malignancies
| Autor: | Patel, Manish *, Hamlin, Paul, Strickland, Donald K, Pandey, Anjali *, Coffey, Greg *, Leeds, Janet M *, Levy, Gallia G., Curnutte, John T., Wagner-Johnston, Nina, Flinn, Ian W. |
|---|---|
| Zdroj: | In Blood 6 December 2014 124(21):3103-3103 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|